Cargando…
A randomized controlled trial to investigate the use of acute coronary syndrome therapy in patients hospitalized with COVID-19: the COVID-19 Acute Coronary Syndrome trial
BACKGROUND: Patients hospitalized with COVID-19 suffer thrombotic complications. Risk factors for poor outcomes are shared with coronary artery disease. OBJECTIVES: To investigate the efficacy of an acute coronary syndrome regimen in patients hospitalized with COVID-19 and coronary disease risk fact...
Ejemplares similares
-
Optimal management of acute coronary syndromes in the era of COVID-19
por: Nijjer, Sukhjinder Singh, et al.
Publicado: (2020) -
Cardiopulmonary exercise testing and efficacy of percutaneous coronary intervention: a substudy of the ORBITA trial( )
por: Ganesananthan, Sashiananthan, et al.
Publicado: (2022) -
Placebo-Controlled Efficacy of Percutaneous Coronary Intervention for Focal and Diffuse Patterns of Stable Coronary Artery Disease
por: Rajkumar, Christopher A., et al.
Publicado: (2021) -
Development of artificial intelligence tools for invasive Doppler-based coronary microvascular assessment
por: Seligman, Henry, et al.
Publicado: (2023) -
Dobutamine Stress Echocardiography Ischemia as a Predictor of the Placebo-Controlled Efficacy of Percutaneous Coronary Intervention in Stable Coronary Artery Disease: The Stress Echocardiography–Stratified Analysis of ORBITA
por: Al-Lamee, Rasha K., et al.
Publicado: (2019)